All comparisons
BMY vs MRK
Bristol-Myers Squibb Company vs Merck & Co., Inc.
Overview
BMYBristol-Myers Squibb Company
Score APrice
$60.93
Fair Value
$66.40
Upside
+9.0%
Convex Score
10/10
MRKMerck & Co., Inc.
Score A+Price
$126.27
Fair Value
$159.81
Upside
+26.6%
Convex Score
10/10
Valuation
BMY
Bear$54.84
Base$97.03
Bull$139.97
Fair Value$66.40
MRK
Bear$113.64
Base$157.21
Bull$190.03
Fair Value$159.81
Quality
BMY
Grade
C
Score
69/100
Classification
Value
Rating
Score A
MRK
Grade
A
Score
95/100
Classification
Compounder
Rating
Score A+
Company Info
| BMY | MRK | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Classification | Value | Compounder |
Verdict
MRK has better risk/reward
MRK: Higher upside potentialMRK: Better quality grade